Pranav Chandrashekar, MD

Cardiology
Accepting new patients
Sees patients age 18 and up
Penn Heart and Vascular Center
Schedule onlineCall 215-615-4949
Headshot of Pranav Chandrashekar, MD
Penn Medicine Provider

About me

  • Assistant Professor of Clinical Medicine (Cardiovascular Medicine)

My education and training

  • Medical School: Bangalore Medical College
  • Residency: Oregon Health & Science University
  • Fellowship: Oregon Health & Science University
  • Fellowship: University of Pennsylvania Health System

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Medicine Rittenhouse Long-Term Acute Care Hospital
Dr. Chandrashekar is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Chandrashekar P, Zaqut A, McCallum R, Rydzak C, Wu EH, Zahr F, Chadderdon SM. Tricuspid Annulus Measurements in Severe Tricuspid Regurgitation: Comparative Analysis of Cardiac-Gated Computed Tomography Versus Three-Dimensional Transesophageal Echocardiography , Struct Heart, 9(10): 2025,100679

Masri A, Bhattacharya P, Medoff B, Ejaz AU, Elman MR, Chandrashekar P, Ives L, Santos AM, Teruya SL, Zhao Y, Huang S, Wang X, Sperry BW, Maurer MS, Soman P, Hanna M. A Multicenter Study of Contemporary Long-Term Tafamidis Outcomes in Transthyretin Amyloid Cardiomyopathy , JACC CardioOncol, 7(3): 2025,282-293

Chandrashekar P., Ashangari C., Chadderdon SM. Imaging of the Mitral Valve , Interv Cardiol Clin, 13(2): 2024,141-153

Prasad P, Chandrashekar P, Golwala H, Macon C, Steiner J. Functional Mitral Regurgitation: patient selection and optimization , Interv Cardiol Clin. , 13(2): 2024,167-182

Kim MM, Prasad M, Burton Y, Kolseth C, Chandrashekar P, Masri A. Comparative Outcomes in Transthyretin Amyloid Cardiomyopathy Vs HFpEF , JAHA, 12(15): 2023,e029705

Prasad M, Kim M, Chandrashekar P, Zhao Y, Fischer KL, Nazer B, Masri A. Evolving epidemiology of transthyretin amyloid cardiomyopathy due to increased recognition in women , Int J Cardiol, 374: 2023,116-119

Chandrashekar P, Masri A. Incidental extra-cardiac uptake of 99mTc-pyrophosphate , J Nucl Cardiol., 29(5): 2022,2721-2723

Chandrashekar P, Desai AK, Trachtenberg BH. Targeted treatments of AL and ATTR amyloidosis , Heart Fail Rev. , 27(5): 2022,1587-1603

Dale Z, Chandrashekar P, Al-Rashdan L, Gill S, Elman M, Fischer KL, Nazer B, Masri A. Routine ambulatory heart rhythm monitoring for detection of atrial arrhythmias in transthyretin cardiac amyloidosis , Int J Cardiol, 358: 2022,65-71

Chen H, Chandrashekar P, Fischer K, Carlson D, Narayan U, Chen J, Masri A. Navigating the Complex Web of Prescribing Amyloidosis Therapeutics: A Primer , J Am Heart Assoc. , 11(7): 2022,e023895